Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
doucumentation of ich and hunt hess CSTK-03
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
Sampling Methodology for Stroke STK
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
First NIHSS performed days after admission CSTK-01
mRS CSTK
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
Time Last Known Well STK
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
PSC CSTK 01 population CSTK, CSTK-01
Assessed for Rehabilitation STK
Is the ambulatory patient considered low risk for VTE? STK
First Radiographic Image, CSTK 07 STK
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
STK-6 "Evidence of Atherosclerosis" STK
Last Known Well STK, STK-04
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
Last known well when symptoms resolve then reoccur STK
Which version of the specifications should be used for stroke data collection? STK
Stroke Measures STK-7 and STK-9 STK
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
One Episode of Care and Thrombolytic Therapy Administration STK
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
Question regarding the new STK OP 1 Measure STK-OP
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
Hunt and Hess & ICH Score Documentation CSTK-03
Clarification of data elements needed CSTK-05b, CSTK-07
What constitutes a failed thrombectomy CSTK-11
Procedure Time Inclusion Terms CSTK-03
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
Inter-rater Reliability and Chart Re-asbstraction STK
Clarification of CSTK-1 Measure Population Requirements CSTK-01
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
Stroke core measure data for PSC hospitals STK
Last Known Well STK-04
Elective carotid intervention documentation STK
Data Element- Violence Risk to Self HBIPS
Can an addendum be added to the medical record? STK-01
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
TEDS for VTE Prophylaxis STK, STK-01
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Abstraction for Last Known Well STK-04
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Jan 2012 Follow-up monitoring VTE-05
Multiple TICI reperfusion grades CSTK-08
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
activity charting ACHF
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
Follow-up to UserQuestionId03Vte101043 VTE-05
CSTK 3 CSTK, CSTK-03
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
Documentation for Stroke Education HF-1
Statin prescibed the day after discharge STK-06, STK-08
Data abstraction for VTE Prophylaxis when administered prior to admission STK
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
Definition of validated and non-validated screening tool for substance use SUB-01
Rationale for Code Stroke Form as the Priority Data Source STK-4
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
Failed attempt at thrombectomy CSTK-08
What value should be selected when VTE prophylaxis is administered several days after admission? STK
thyroid CA PC-01
Reason for Not Administering Antithrombotic Therapy? STK
SCIP questions related to the April 2010 manual SCIP
Late Coded Stroke STK-4 and STK-5 STK, STK-4
Time Last Known Well is after hospital arrival STK-04
Continuing Care Plan Document Questions HBIPS
Time Last Know Well -Stroke STK
Questions about sampling? ACHF
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
How is Length of Stay (LOS calculated for STK-1?) STK-01
Pre-transfusion platelet count allowable value BM-04b
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Triglyceride >400mg/dL STK
How to abstact Last Known Well when there is too much information? STK
Statin therapy for patients 75yrs and older STK
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
Patient Ambulatory At End of Hospital Day 2 STK
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
Positive over negative findings STK-OP
Written discharge instructions for warfarin therapy VTE-05
HBIPS Discharge Status HBIPS
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Date Last Known Well STK
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
What would I document as Last Known Well? STK, STK-4
Data Abstraction for "Last Known Well" STK
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
NIHSS versus mNIHSS CSTK-05
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
Antithrombotic Administration after t-PA STK-05
Referral to Next Level of Care HBIPS
Discharged on Anticoagulation Therapy STK
Last Known Well Version 5.2 STK-4
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
Arrival Time for STK, CSTK and STK-OP Measures STK
Optimal Medication Management ACHF
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
Pneumonia diagnosis: ED/Direct Admint PN
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
What terms can be used for Comfort Measures Only? STK
Reason for not prescribing antithrombotic therapy at hospital discharge STK
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Documentation of Last Known well STK, STK-4
Admission Date STK-01
STK-10 Assessed for Rehabilitation Services STK-10
IV Alteplase STK-OP
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
STK 10 Assessed for rehabilitation STK-10
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
NIHSS time STK
Will Evidence of Atherosclerosis remain a data element? STK-06
Support System ACHF
Follow-up to UserQuestionId03Stk100628 STK
Dabigatran (PRADAXA use in Stroke Patients) STK
Patient Population CSTK
CSTK-01 Procedures and Timing 1 calculation CSTK-01
Stroke Education Documentation Examples STK-08
Documentation for Rehabilitation Assessment STK-10
Documentation Compliance for IV t-PA STK, STK-04
History of low vertical incision documented BUT no documentation of classical incision. PC-01
ABstraction for Date Last Known Well STK
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
Will Primary Stroke Certification continue? STK
Reason for Not Initiating IV Thrombolytic STK
Procedures Performed During Hospitalization ACHF
Are patients that stroke while an inpatient included in the measure population? STK
Define who is considered a stroke team for STK 4. STK
NIHSS Score Clarification CSTK-01
Rehabilitation Assessment STK
Activity specifics ACHF
Continuing Care Plan - Reason for Hospitalization HBIPS
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
HBIPS-1 Timeframe for Screening Questions HBIPS
Transfer in patients that are intubated CSTK-01
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
Sampling Requirements for CSTK CSTK
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
Mother's choice not to breast feed PC-05
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7
Exclusive breast milk feeding definition PC
Elective Carotid Intervention STK
Time of the teleneurology NIHSS CSTK-01
Next Level of Care Provider Same as Hospital Provider HBIPS
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
Number of cases needed for submission BM
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04
Sampling when both STK and CSTK are collected by a HCO CSTK
Stroke Diagnosed Mid-Hospital Stay STK-5
Documention of Stroke education at discharge, STK-08
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Primary Stroke Certification and Transition to Stroke Core Measures STK
Risk of Violence to Self HBIPS, HBIPS-1
Code 433.10 and Transient Ischemic Attack STK
Time NIHSS performed CSTK-01
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
Is admission day counted as day 1 for STK-1? STK
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
Birth Weight suggested Sources PC-06
Does the following documentation meet education regarding Risk factors for stroke? STK
Non Aneurysmal SAH Documentation CSTK-06
Patients transferred after t-PA STK
Arrival time for transferred patients CSTK-07
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
Date/Time of First Pass for CSTK-7 CSTK
Abstraction Tools ASR-OP-1
Stroke that occurs after admission CSTK
Who should perform mRS? CSTK-02
CSTK Procedure Times CSTK
Can we use E/M code 99211? ACHF
STK-4 IV Thrombolytic Therapy STK
Patient Referral to Next Level of Care Provider HBIPS
Earliest principal procedure time/first pass time CSTK
Abstraction for Clinical Trial (STK ) STK
Admitted for elective carotid intervention STK
Multiple Procedure Times CSTK, CSTK-01
Is intensive dosing of statin required to meet STK-6? STK
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
HBIPS- Restraint and Seclusion in ED HBIPS-3
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
Expired after discharge CSTK-02
Is this considered a stroke clinical trial patient? STK
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Multiple EMRs HBIPS
Why are there not more contraindications to vaginal deliveries? PC
Last Known Well Y/N? STK-4
Comparative Data for Stroke Measures STK
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
Importance of exclusive breast milk feeding PC
Reason for not giving Nimodipine within 24 hours CSTK
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
CSTK4 documentation time? CSTK-04
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK
Why has this indicator has changed to include the word "elective"? STK
Why aren't more exclusions to elective delivery considered? PC
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
Stroke Measure Requirements STK
Documentation of Stroke Education STK-08
Follow-up to UserQuestion102705 CSTK
Refusal of SCD's STK, STK-01
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
What is the Date and Time of Last Well Known? STK-04
Clairfy time to recanalization CSTK, CSTK-07
Pradaxa (dabigatran prescribed at discharge) STK-02
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
Statins at Discharge STK-06
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
DVT Prophylaxis and Ambulation STK, STK-01
Reason for No VTE Prophylaxis STK, STK-01
Unable to Calculate LDL Value Due to High Triglycerides STK-06
Evidence of Atherosclerosis STK
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
Does all medical record documentation need to be dated and timed? STK
Reason for extending IV tPA STK-4
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Please submit all outpatient questions to QnetQuest.org OP
Discharge Code and Transfers of Patients STK-OP
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
Documentation added to D/C summary after discharge STK-6
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
Follow-up to UserQuestionId03Stk100984 STK-04
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
Arrival time Abstraction. CSTK-11
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
What is the Date and Time Last Known Well? STK-04
ICH score documentation CSTK-03b
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
Stroke Module STK
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
Pre-anemia screening BM
Psychiatic Care Setting -Patient Inclusion HBIPS
Documentation for tPA exclusion STK, STK-04
Positive Brain Image CSTK
CSTK 4 Denominator Population CSTK-04
Need information about the required import file specifications BM
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Sampling Requirements for CSTK CSTK
Assessed for Rehabaliitation Services STK-10
Comprehensive Stroke (CSTK Sub-Populations) CSTK
What should we do when conflicting or multiple times of last known well are documented? STK-04
Graduated Compression Stocking (GCS) STK
Procedure codes for HF outpatients ACHF
MER Eligibility CSTK
HBIPS Event Dates Prior to Admission HBIPS
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
ICD-9-CM Code 433.10 STK
STK-6 Data Entry in CMIP for Q1 2010 STK
Can I use VTE used during the Observation, given prior to hospital admission STK-1
Retirement of STK-7 Dysphagia Screen STK-07
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
Recommended ways to obtain mRS CSTK, CSTK-02
MER Attempted During this Encounter - Clot Dissolved CSTK-11
STK-5 Antithrombotic - LOVENOX SQ STK
NIHSS Timed After Discharge CSTK-01
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Time Last Known Well - Conflicting Physician Documentation STK-04
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
Stroke VTE Prophylaxis STK-01
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
COVID-19 CSTK
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Functional Status at Discharge ACHF
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
What is the Admission Date? STK

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine